The many faces of the anti-COVID immune response

The novel 2019 strain of coronavirus is a source of profound morbidity and mortality worldwide. Compared with recent viral outbreaks, COVID-19 infection has a relatively high mortality rate, the reasons for which are not entirely clear. Furthermore, treatment options for COVID-19 infection are curre...

Full description

Saved in:

Bibliographic Details
Published in:	The Journal of experimental medicine Vol. 217; no. 6
Main Authors:	Vardhana, Santosha A, Wolchok, Jedd D
Format:	Journal Article
Language:	English
Published:	United States 01.06.2020
Subjects:	Adaptive Immunity - drug effects Adaptive Immunity - immunology Betacoronavirus - drug effects Betacoronavirus - immunology Betacoronavirus - pathogenicity Coronavirus Infections - immunology Coronavirus Infections - pathology Coronavirus Infections - therapy COVID-19 Cytokine Release Syndrome - immunology Cytokine Release Syndrome - pathology Cytokine Release Syndrome - therapy Humans Hypoxia - pathology Hypoxia - therapy Immunity, Innate - drug effects Immunity, Innate - immunology Inflammation - immunology Inflammation - pathology Inflammation - therapy Interleukin-6 - antagonists & inhibitors Interleukin-6 - immunology Lymphopenia - immunology Lymphopenia - pathology Lymphopenia - therapy Macrophages - immunology Macrophages - pathology Middle East Respiratory Syndrome Coronavirus - immunology Middle East Respiratory Syndrome Coronavirus - pathogenicity Pandemics Pneumonia, Viral - immunology Pneumonia, Viral - pathology Pneumonia, Viral - therapy Respiration, Artificial Respiratory Distress Syndrome - pathology Respiratory Distress Syndrome - therapy SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus - immunology Severe acute respiratory syndrome-related coronavirus - pathogenicity
ISSN:	1540-9538, 1540-9538
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!